Zebra Technologies Corporation (ZBRA) Stock Price & Analysis
Zebra Technologies Corporation (ZBRA) closed at USD 384.16 on Thursday, October 22, 2026, down 1.75% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 384.16; the Oct 22, 2026 session ranged USD 373.9–387.94 on volume of 589,127 shares. Market capitalization is —, with a 52-week range of USD 199.05–392.78 (NMS). Source: Nexqual, retrieved October 23, 2026 at 09:27 UTC.
Also available as compact Markdown for AI agents: nexqual.com/ZBRA.md
Key facts (ZBRA)
- Last four reported quarters (through Jul 4, 2026): revenue $5.85B, net income $539M (9.2% margin), free cash flow $904M (SEC filings).
- 2 of 80 tracked superinvestors hold ZBRA (13F, Q2 2026): 1 new, 1 added, 0 reduced, 0 unchanged.
- Analysts: Buy (mean 2.19 on a 1–5 scale) (16 analysts), mean target USD 414.85 (range 350–460).
- Total return with dividends: 1Y +22.4% vs S&P 500 +14.9%; 5Y -27.2% vs S&P 500 +80.3%.
- Next earnings: 2026-11-03, EPS estimate USD 4.91, revenue estimate $1.57B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (ZBRA)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $5.63B | $5.78B | $4.58B | $4.98B | $5.40B | $5.85B |
| Gross profit | $2.63B | $2.62B | $2.12B | $2.41B | $2.59B | — |
| Operating income | $979M | $529M | $481M | $742M | $700M | $858M |
| Net income | $837M | $463M | $296M | $528M | $419M | $539M |
| EPS (diluted) | $15.52 | $8.80 | $5.72 | $10.18 | $8.18 | — |
| Free cash flow | $1.01B | $413M | -$91.0M | $954M | $831M | $904M |
| Gross margin | 46.7% | 45.4% | 46.3% | 48.4% | 48.1% | — |
| Operating margin | 17.4% | 9.2% | 10.5% | 14.9% | 13.0% | 14.7% |
| Net margin | 14.9% | 8.0% | 6.5% | 10.6% | 7.8% | 9.2% |
| Revenue growth | +26.5% | +2.7% | -20.7% | +8.7% | +8.3% | — |
| Cash + short-term investments | $332M | $105M | $137M | $901M | $125M | — |
| Total debt | $991M | $2.02B | $2.22B | $2.17B | $2.50B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jul 4, 2026) (ZBRA)
P/E at fiscal year-ends: Dec 2025 29.7x, Dec 2024 37.9x, Dec 2023 47.8x.
Superinvestors (SEC 13F-HR, Q2 2026) (ZBRA)
2 of 80 tracked investors hold ZBRA. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| John Rogers | Ariel Investments | 2.42% | $243M | Added +18.7% |
| Richard Pzena | Pzena Investment Management | <0.01% | $358K | New position |
Analysts (ZBRA)
Consensus Buy (mean 2.19 on a 1–5 scale), 16 analysts; mean target USD 414.85 (low 350, high 460).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-12 | Citigroup | Target raised | Neutral | $396 → $400 |
| 2026-10-12 | Barclays | Target raised | Overweight | $410 → $416 |
| 2026-10-05 | Truist Securities | Target raised | Hold | $355 → $378 |
| 2026-09-15 | Needham | Target raised | Buy | $410 → $435 |
| 2026-08-05 | TD Cowen | Target raised | Buy | $400 → $450 |
| 2026-08-05 | Citigroup | Target raised | Neutral | $306 → $396 |
| 2026-08-05 | Truist Securities | Target raised | Hold | $296 → $355 |
| 2026-08-05 | BNP Paribas | Target raised | Outperform | $370 → $455 |
| 2026-08-05 | Keybanc | Target raised | Overweight | $305 → $430 |
| 2026-08-05 | Barclays | Target raised | Overweight | $346 → $410 |
| 2026-08-05 | Needham | Target raised | Buy | $345 → $410 |
| 2026-07-13 | Citigroup | Target raised | Neutral | $284 → $306 |
Total return (dividends reinvested) (ZBRA)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +22.4% | -27.2% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +22.5% | -6.2% |
| Volatility (annualized) | 47.2% | 41.6% |
| Max drawdown | -36.5% (Oct 2025→Mar 2026) | -67.0% (Dec 2021→Mar 2026) |
ZBRA analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $4.91 | $4.55 | +7.8% | $1.57B | 15 |
| Next quarter (ends Dec 2026) | $5.21 | $4.92 | +6.0% | $1.61B | 14 |
| Current fiscal year (ends Dec 2026) | $21.06 | $18.56 | +13.5% | $6.23B | 16 |
| Next fiscal year (ends Dec 2027) | $22.29 | $20.72 | +7.6% | $6.62B | 16 |
Key Statistics (as of October 23, 2026 at 09:27 UTC)
| Price | USD 384.16 |
|---|---|
| Change | ▼ 1.75% (down) |
| Previous Close | USD 384.16 |
| Open | USD 384.16 |
| Day Range | USD 373.9 – 387.94 |
| 52-Week Range | USD 199.05 – 392.78 |
| Volume | 589,127 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (ZBRA)
Nexqual's technical model rates ZBRA "STRONG BUY" based on 5 bullish and 0 bearish signals across 127 daily candles, as of October 23, 2026 at 09:27 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 55.6 (neutral) |
| vs SMA50 | Above (USD 366.19) |
| MACD | 6.45 (positive) |
Analyst Ratings (ZBRA)
Wall Street analysts rate ZBRA "Buy" based on 16 analysts, with a mean price target of USD 414.85 (range USD 350–460), per Nexqual as of October 23, 2026 at 09:27 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 16 |
| Mean Target | USD 414.85 |
| High Target | USD 460 |
| Low Target | USD 350 |
| Buy / Hold / Sell | 10 / 6 / 0 |
Earnings (ZBRA)
| Next Earnings Date | 2026-11-03 |
|---|---|
| EPS Estimate | USD 4.91 |
| Revenue Estimate | $1.57B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 6.35 vs est 4.38 ▲ beat |
| 2026-03-31 | USD 4.75 vs est 4.25 ▲ beat |
| 2025-12-31 | USD 4.33 vs est 4.33 ▼ miss |
| 2025-09-30 | USD 3.88 vs est 3.75 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Financials & Fundamentals (ZBRA)
| Total Revenue | $5.85B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +20.40% |
| Gross Margin | +49.58% |
| Operating Margin | +21.26% |
| Profit Margin | +9.22% |
| ROE | +15.29% |
| Debt / Equity | 0.86 |
| Current Ratio | 0.52 |
| Total Cash | $157.00M |
| Total Debt | $2.96B |
| Free Cash Flow (last four quarters to Jul 2026, SEC 10-Q / 10-K) | $904.00M (15.5% of revenue) |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Financial Health Score (ZBRA)
Nexqual rates Zebra Technologies Corporation's overall financial health "Solid" across five dimensions, as of October 23, 2026 at 09:27 UTC.
| Growth | Solid — Revenue +8% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 50%, operating 21% (last 12 months) |
| Balance Sheet | Weak — $157M cash and investments vs $2.78B debt (Jul 2026, SEC) |
| Cash Flow | Strong — FCF $904M (last 4 quarters to Jul 2026, SEC), 15% margin |
| Efficiency | Solid — ROE 15%, ROA 7.3% |
Ownership (ZBRA)
| Insider Ownership | +0.85% |
|---|---|
| Institutional Ownership | +106.52% |
| Shares Outstanding | 47.31M |
| Float | 46.87M |
| Short % of Float | +4.10% |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ASTS | AST SpaceMobile, Inc. | USD 38.77 | ▼ 5.21% |
| ERIC | Ericsson | USD 10.38 | ▼ 0.48% |
| UI | Ubiquiti Inc. | USD 595.62 | ▼ 2.25% |
| VIAV | Viavi Solutions Inc. | USD 30.3 | ▼ 14.38% |
| VSAT | ViaSat, Inc. | USD 59 | ▼ 5.74% |
| CIEN | Ciena Corporation | USD 322.64 | ▼ 10.71% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:27 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt